Thomas Steyer Farallon Capital Management
Thomas Steyer founded Farallon Capital Management, a pioneering multi-strategy firm spanning credit, equities, real estate, and event-driven investing. Farallon became known for rigorous research and opportunistic capital allocation across cycles. Although Steyer later focused on public advocacy, the Farallon name remains important in hedge fund history and ongoing 13F tracking.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NUAN
Nuance Communications, Inc.
NUAN
|
+$387M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$332M |
| 3 |
ServiceNow
NOW
|
+$265M |
| 4 |
New York Times
NYT
|
+$189M |
| 5 |
MXIM
Maxim Integrated Products
MXIM
|
+$152M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$456M |
| 2 |
IPHI
INPHI CORPORATION
IPHI
|
+$311M |
| 3 |
IQVIA
IQV
|
+$278M |
| 4 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
+$277M |
| 5 |
New Oriental
EDU
|
+$192M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 29.51% |
| 2 | Technology | 16.43% |
| 3 | Financials | 13.12% |
| 4 | Communication Services | 9.43% |
| 5 | Industrials | 7.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$809B
| $2.25B | 9.17% |
5,246,000
+3,011,000
| +135% | +$1.26B |
|
|
2
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$809B
| $1.5B | 6.13% |
+3,510,000
| New | +$1.47B |
|
|
ALXN
3
DELISTED
Alexion Pharmaceuticals
ALXN
| $1.42B | 5.78% |
7,707,500
+1,932,500
| +33% | +$332M |
|
4
Willis Towers Watson
WTW
$31.8B
| $799M | 3.26% |
3,474,660
+350,460
| +11% | +$87.2M |
|
|
5
IQVIA
IQV
$42.8B
| $695M | 2.84% |
2,866,836
-1,202,345
| -30% | -$278M |
|
6
Thermo Fisher Scientific
TMO
$233B
| $678M | 2.77% |
1,344,078
+189,000
| +16% | +$89.2M |
|
7
Aon
AON
$75.3B
| $631M | 2.58% |
2,642,614
+188,420
| +8% | +$46M |
|
|
XLNX
8
DELISTED
Xilinx Inc
XLNX
| $594M | 2.42% |
4,106,000
+410,000
| +11% | +$52.1M |
|
9
Boston Scientific
BSX
$73B
| $544M | 2.22% |
12,716,619
-106,250
| -0.8% | -$4.47M |
|
|
10
Alphabet (Google) Class C
GOOG
$4.18T
| $534M | 2.18% |
4,258,340
-3,828,680
| -47% | -$456M |
|
11
T-Mobile US
TMUS
$196B
| $499M | 2.04% |
3,448,481
-660,345
| -16% | -$91.1M |
|
|
MXIM
12
DELISTED
Maxim Integrated Products
MXIM
| $476M | 1.94% |
4,515,000
+1,557,600
| +53% | +$152M |
|
13
Microsoft
MSFT
$3.59T
| $464M | 1.89% |
1,713,078
-203,170
| -11% | -$51.6M |
|
|
WORK
14
DELISTED
Slack Technologies, Inc.
WORK
| $462M | 1.89% |
10,437,300
+3,210,000
| +44% | +$137M |
|
15
Aramark
ARMK
$15.8B
| $455M | 1.86% |
16,912,166
+1,859,363
| +12% | +$51M |
|
16
Fidelity National Information Services
FIS
$21.3B
| $439M | 1.79% |
3,100,358
-41,960
| -1% | -$6.23M |
|
17
Wabtec
WAB
$50.3B
| $434M | 1.77% |
5,274,851
+327,905
| +7% | +$26.6M |
|
18
Meta Platforms (Facebook)
META
$1.4T
| $426M | 1.74% |
1,226,545
-172,660
| -12% | -$55.4M |
|
19
RTX Corp
RTX
$283B
| $405M | 1.65% |
4,749,986
-32,425
| -0.7% | -$2.73M |
|
|
NUAN
20
DELISTED
Nuance Communications, Inc.
NUAN
| $399M | 1.63% |
+7,337,500
| New | +$387M |
|
|
BBL
21
DELISTED
BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares)
BBL
| $370M | 1.51% |
6,200,000
+2,199,479
| +55% | +$134M |
|
22
Salesforce
CRM
$171B
| $361M | 1.47% |
1,477,615
+50,740
| +4% | +$11.7M |
|
23
Broadcom
AVGO
$1.75T
| $350M | 1.43% |
7,344,000
+521,530
| +8% | +$24.2M |
|
24
Centene
CNC
$32.1B
| $346M | 1.41% |
4,750,000
-875,000
| -16% | -$59.9M |
|
25
Mastercard
MA
$509B
| $339M | 1.38% |
927,600
-58,320
| -6% | -$21.7M |
|
Similar funds
Thomas Steyer's Q2 2021 Portfolio in Review
As of Q2 2021, Thomas Steyer held 397 positions worth $24.5B, up 22% from $20.1B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Thomas Steyer deployed $2.47B of net new capital in Q2 2021, opening 164 new positions and adding to 36 existing holdings. Its largest new stake was Nuance Communications, Inc.: 7,337,500 shares worth $399M.
By sector, the portfolio is most concentrated in Healthcare at 30% of assets, down from 36% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $456M trimmed.
- Thomas Steyer's largest Q2 2021 buy was Nuance Communications, Inc.: 7,337,500 shares worth $399M.
- Thomas Steyer added most to Alexion Pharmaceuticals in Q2 2021, an estimated $332M increase.
- Thomas Steyer's biggest Q2 2021 reduction was Alphabet (Google) Class C, cutting an estimated $456M.
- Thomas Steyer fully exited INPHI CORPORATION in Q2 2021, selling an estimated $311M.
- Thomas Steyer's ten largest holdings make up 39% of its $24.5B portfolio in Q2 2021.
- Thomas Steyer opened 164 new positions and closed 100 in Q2 2021.
- Thomas Steyer's portfolio value rose 22% quarter-over-quarter to $24.5B.
Based on Farallon Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.